Net Cash Provided by (Used in) Operating Activities |
-589K |
USD |
-116% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-5.11M |
USD |
-1073% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
5.7M |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
5.64M |
shares |
|
Q1 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
3.33K |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
4.28K |
USD |
-89.1% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
794K |
USD |
+101% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
794K |
USD |
+101% |
Q4 2023 |
FY 2023 |
Deferred Income Tax Expense (Benefit) |
77.7K |
USD |
|
Q1 2024 |
Q1 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q1 2024 |
Q1 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Additional Paid in Capital |
1.17M |
USD |
-65.4% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
50.9K |
USD |
|
Q4 2022 |
FY 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
Q1 2024 |